Case report: challenges in monitoring and treatment of anthracycline induced cardiotoxicity in young adults with osteosarcoma

Case report: challenges in monitoring and treatment of anthracycline induced cardiotoxicity in young adults with osteosarcoma

Abstract Neo(adjuvant) systemic treatment regimens containing anthracyclines such as doxorubicin cause a significant risk of heart failure. These regimens are one of the corner stones of osteosarcoma treatment, and therefore several guidelines are in place to steer cardiotoxicity monitoring through...

Full description

Bibliographic Details
Main Authors: Julius C. Heemelaar, Jeroen Janson, Jerry Braun, Frank M. Speetjens, Michiel A. J. van de Sande, Juan D. V. Hugo, Daniela Q. C. M. Barge-Schaapveld, Saskia L. M. A. Beeres, Laurens F. Tops, Hans Gelderblom, M. Louisa Antoni
Format: Article
Language:English
Published: BMC 2022-11-01
Series:Cardio-Oncology
Subjects:
Osteosarcoma
Doxorubicin
Cardiotoxicity
Heart failure
Case report
Left ventricular assist device
Online Access:https://doi.org/10.1186/s40959-022-00145-y

Internet

https://doi.org/10.1186/s40959-022-00145-y

Similar Items